FindTrial
Sign In

To compare .75% ropivacaine with dexmedetomidine and .75% ropivacaine with fentanyl undergoing infraumblical surgeries under spinal anesthesia

“A comparative study between intrathecal hyperbaric ropivacaine 0.75% with dexmedetomidine vs hyperbaric ropivacaine 0.75% with fentanyl in patients undergoing lower abdominal surgeries under spinal anaesthesia ? - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061586
Enrollment
80
Registered
2024-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: hyperbaric ropivacaine 0.75% with dexmedetomidine vs hyperbaric ropivacaine 0.75 with fentanyl: .75% hyperbaric ropivacaine 3 ml with with fentanyl 25microgram and .75% hyperbaric ropiv

Sponsors

Jawahar Lal medical college ajmer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient belonging to ASA class 1 and 2 undergoing various infraumblical surgeries

Exclusion criteria

Exclusion criteria: Patient refusal uncooperative Any known history of allergies Local pathology at the site of injection Bleeding disorder

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of intrathecal hyperbaric ropivacaine 0.75% with dexmedetomidine vs hyperbaric ropivacaine 0.75 with fentanyl in patient undergoing lower abdominal surgeries under spinal anaesthesia within baselineTimepoint: To assess the efficacy of intrathecal hyperbaric ropivacaine 0.75% with dexmedetomidine vs hyperbaric ropivacaine 0.75 with fentanyl in patient undergoing lower abdominal surgeries under spinal anaesthesia within baseline—

Secondary

MeasureTime frame
To assess the duration of sensory & motor block, compare hemodynamic Changes if any total rescue analgesia consumption at baselineTimepoint: Assess as grading point system At baseline , at 4week ,at 8 week—

Countries

India

Contacts

Public ContactDr shiva mishra

JLN medical college jln

Veenapatodi@gmail.com9414008276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026